NeoGenomics is thrilled to be exhibiting at this year's San Antonio Breast Cancer Symposium (SABCS). NeoGenomics leverages its leadership in precision diagnostics to deliver a complete suite of tests that meet the clinical demands for breast cancer patients at any stage.
Make sure to stop by Booth #841 to speak with a NeoGenomics representative to learn more and mark your calendar for these RaDaR® presentations at SABCS this year:
Product Theatre
Thursday, December 7 | 12:30 pm | Product Theater B
**Lunch will be provided**
MRD and Monitoring in breast cancer: a RaDaR review and panel discussion
Speaker: David Cescon, MD, PhD, Princess Margaret Cancer Centre, University of Toronto
Panelist: Pat Whitworth, MD, FACS, FSSO, Nashville Breast Center
Panelist: Wolfgang Janni, MD, PhD, University of Ulm
Panelist: Derek Lyle, MD, NeoGenomics Laboratories
Poster Presentations
Poster #PS06-08
Longitudinal Neoadjuvant and Post-operative Evaluation of Circulating Tumor DNA in Early Breast Cancer using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort.
Speaker: Mitchell Elliott, MD
Princess Margaret Cancer Centre,
University of Toronto
Poster #P02-14-03
Novel Metrics of HER2 Heterogeneity in HER2-Positive and HER2-Low Breast Cancer via High Dimensional Multiplexed Immunofluorescence Spatial Profiling
Speaker: Anna Juncker-Jensen
NeoGenomics Laboratories